Results 251 to 260 of about 523,140 (287)
Chemical autoligation with phosphorothioate- and sulfonamide-terminated DNA via intramolecular cross-activation. [PDF]
Yokoe H+7 more
europepmc +1 more source
Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery
Machine Learning (ML) is revolutionizing cancer nanomedicine by optimizing nanoparticle (NP) design and drug delivery. This review summarizes ML applications across all stages of NP drug delivery, along with a discussion of ongoing challenges and future directions.
Qingquan Wang+5 more
wiley +1 more source
Oligo-seq protocol for mapping DNA motifs targeted by base editors. [PDF]
Ortega P+3 more
europepmc +1 more source
Dysregulated RNA splicing is an underappreciated molecular feature of cancer. By integrating murine and cellular models with patient specimens of lung adenocarcinoma, this study demonstrates that RAC1B, rather than RAC1A isoform, promotes tumorigenesis and presents a potent therapeutic target for lung cancer. Mechanistically, RAC1B preferentially binds
Yueren Yan+19 more
wiley +1 more source
Nuclear Retention of mRNAs Through Paraspeckle Protein Binding to a Sequence Determinant in 3'UTR. [PDF]
Jacq A+10 more
europepmc +1 more source
These study underscores the pivotal role of neutrophil‐derived myeloid‐related protein 14 (MRP14) in the pathophysiology of acute ischemic stroke (AIS). MRP14 not only disrupts mitochondrial function, thereby inhibiting microglial phagocytosis of neutrophils, but also activates microglial pyroptosis, exacerbating neuroinflammation following AIS ...
Huijuan Jin+10 more
wiley +1 more source
Antisense oligonucleotide therapies for monogenic disorders. [PDF]
Krey-Grauert I, Ferro I, Wagner M.
europepmc +1 more source
STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao+20 more
wiley +1 more source